Vaccines

George Mason University researchers are taking advantage of DNA molecules’ self-assembly properties to develop vaccines rapidly, publishing their findings in Communications Biology

Mason's Michael Buschmann and his team have developed technology that could help make COVID-19 vaccines less costly, with fewer side-effects and more available.